corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20111 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 185 of 202 pages ‹ First  < 183 184 185 186 187 >  Last ›

HSL9503
Teagarden JR, Hubler GL.
Corporate patient management system
Hospital Pharmacy 1990 Jun;25:520, 526

HSL13293
Maheswaranand D, Sternthal B.
The Effects of Knowledge, Motivation, and Type of Message on Ad Processing and Product Judgments
Journal of Consumer Research 1990 Jun;17:(1):66-73
http://www.journals.uchicago.edu/action/jstor?sici=0093-5301%28199006%2917%3A1%3C66%3ATEOKMA%3E2.0.CO%3B2-C&doi=10.1086%2F208537

HSL4121
Tietze KJ, Smith MC.
More on sex and racial bias in pharmaceutical advertisements.
N Engl J Med 1990 May 24;322:(21):1534

HSL4051
[No authors listed] Related Articles, Links Conflicts of interest in medical center/industry research relationships.
Council on Scientific Affairs and Council on Ethical and Judicial Affairs.
JAMA 1990 May 23-30;263:(20):2790-3

HSL4077
McLauchlan B.
For the price of a pen.
N Z Med J 1990 May 23;103:(890):250

HSL1874
Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, McKinney WP.
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.
J Gen Intern Med 1990 May-Jun;5:(3):240-3
http://www.ncbi.nlm.nih.gov/pubmed/2341925

HSL4112
Smeeding JE.
Direct-to-consumer advertising of prescription pharmaceuticals: strategic issues for the pharmaceutical industry.
Top Hosp Pharm Manage 1990 May;10:(1):40-64

HSL4142
Sweeney GD.
A submission to the College of Physicians & Surgeons of Ontario on the relationship between the faculty and the Canadian pharmaceutical industry
1990 May

HSL9502
Getting a grip on Medicaid costs
National Association of Retail Druggists Journal 1990 May;112:32-35

HSL9504
Prescription-to-nonprescription switches to be dominant force in nonprescription market
American Journal of Hospital Pharmacy 1990 May;47:960

HSL9505
Lederle to donate cefixime to homeless persons through community health centers
American Journal of Hospital Pharmacy 1990 May;47:964

HSL9507
Sesti LM.
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W. D. Michigan
Journal Michigan Pharmacist 1990 May;28:170-171

HSL9508
Klepcyk JC.
Marketing a discharge prescriptions program
American Journal of Hospital Pharmacy 1990 May;47:1006

HSL4081
Murdoch JC.
For the price of a pen!
N Z Med J. 1990 Apr 25;103:(888):190

HSL4117
Steinbrook R, Lo B.
Informing physicians about promising new treatments for severe illnesses.
JAMA 1990 Apr 18;263:(15):2078-82

HSL4028
Physicians and the pharmaceutical industry.
Ann Intern Med 1990 Apr 15;112:(8):624-6

HSL4141
Mansfield PR.
1990 Apr 9

HSL3699
US General Accounting Office.
FDA drug review. Postapproval risks 1976-1985. Report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations.
Washington DC.: Committee on Government Operations. 1990 Apr

HSL4139
MaLAM Letter follow up—were “brain tonic” results just a stroke of luck?
MaLAM Newsletter 1990 Apr

HSL4140
Re: the promotion of sulbutiamine
1990 Apr

HSL9506
McCarthy R.
Triplicate prescriptions: benzodiazepines
American Druggist 1990 Apr;201:64-66, 68, 70

HSL4106
Schonhofer PS.
Ginkgo biloba extracts.
Lancet 1990 Mar 31;335:(8692):788

HSL4138
A review of attitudes, impressions, problems, restraints and policies existing regarding the present process of government control over drug advertising in Canada
1990 Mar 15

HSL4108
McCarthy M, Aarons D, Scott HV.
Cefixime: in vitro sensitivity of respiratory and urinary tract infection organisms.
N Z Med J 1990 Mar 14;103:(885):106

HSL9162
Bradley C, Blenkinsopp A.
Over the counter drugs: The future for self medication
BMJ 1996 Mar 9;312:629-632
http://www.bmj.com/cgi/content/full/312/7034/835

HSL1875
Caplan RM.
CME ethics, continued.
Iowa Med 1990 Mar;80:(3):135

HSL4132
MaLAM letter follow up—FCE admit data sheet was obsolete
MaLAM Newsletter 1990 Mar;2

HSL4133
MaLAM letter follow up—Uteplex withdrawn except in Europe
MaLAM Newsletter 1990 Mar;

HSL4134
Re: the promotion of Aspro for children
1990 Mar

HSL4135
Direct-to-consumer advertising becoming more accepted
Medical Marketing & Media 1990 Mar;25:(3):64

HSL4151
Boyd B.
What you see depends on where you sit: Department of Health perspective
1990 Mar

HSL4152
Durham J.
Pharmaceutical promotion in New Zealand—a view from general practice
1990 Mar

HSL16655
Connelly DP, Rich EC, Curley SP, Kelly JT.
Knowledge resource preferences of family physicians.
J Fam Pract 1990 Mar;30:(3):353-9
http://www.ncbi.nlm.nih.gov/pubmed/2248632

HSL4069
Jenike MA.
Relations between physicians and pharmaceutical companies: where to draw the line.
N Engl J Med 1990 Feb 22;322:(8):557

HSL4030
Anderton D.
Advertising acyclovir.
Lancet 1990 Feb 3;335:(8684):288

HSL4066
Herxheimer A, Collier J.
Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation.
BMJ 1990 Feb 3;300:(6720):307-11

HSL4104
Schiff G.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990 Feb 2;263:(5):658-9

HSL9511
Senate studies how private sector negotiates with pharmaceutical manufacturers for lower prices
American Pharmacy 1990 Feb;8

HSL9512
Smith JM.
Information on unlicensed products
British Journal of Pharmaceutical Practice 1990 Feb;12:39

HSL9513
Leblang TR.
Defective Rx drugs
American Druggist 1990 Feb;201:50

HSL4045
Campbell B.
Throw-away journals: tactics for dealing with office waste
CMAJ 1990 Jan 15;142:(2):100

HSL4064
Harvey K.
Pharmaceutical promotion.
Med J Aust 1990 Jan 15;152:(2):57-8

HSL4101
Salem AG.
Medical education and the pharmaceutical industry.
J Gen Intern Med 1990 Jan-Feb;5:(1):91-2

HSL9510
Third parties could help pharmacy
American Druggist 1990 Jan;201:12

HSL9515
Human side of rising drug prices
National Association of Retail Druggists Journal 1990 Jan;112:20-23

HSL4025
Consumer information
Lancet 1990;(335):1395

HSL4026
MaLAM replies to IFPMA letter
Scrip 1990;(1523):26

HSL4027
Ahmad SR, Bhutta ZA.
A survey of pediatric prescribing and dispensing in Karachi
Journal of the Pakistan Medical Association 1990;40:126-130

HSL4029
American Federation for Clinical Research Guidelines for Avoiding Conflict of Interest
Clinical Research 1990;38:239-240

HSL4031
Andrew M.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:65

HSL4034
Berry J.
Doctors, drug companies, and gifts
JAMA 1990;263:2178

HSL4035
Berube B.
Marketing ibuprofen
Canadian Pharmaceutical Journal 1990;123:402

HSL4036
Berube B.
The slick sell: the pharmacist’s view
Canadian Pharmaceutical Journal 1990;123:400-401

HSL4037
Berube B.
The subtle sell: an overview
Canadian Pharmaceutical Journal 1990;123:397-398

HSL4038
Berube B.
Who regulates drug advertising in Canada
Canadian Pharmaceutical Journal 1990;123:402, 418

HSL4039
Ethical responsibilities of physicians in their dealings with pharmaceutical companies
Annals of the Royal College of Physicians and Surgeons of Canada 1990;23:45-48

HSL4040
Blouin , C .
Hypertension and eating habits
Canadian Medical Association Journal 1990;143:460-461

HSL4041
Bricker EM.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64

HSL4042
Burkle JS.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407-408

HSL4043
Bushe CJ.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:65

HSL4047
Canavan B.
Forging the alliance: CME’s relationship with industry
Journal of Continuing Education in the Health Professions 1990;10:123-128

HSL4048
Chetley A.
A healthy business? World health and the pharmaceutical industry
Zed Books 1990;
http://www.amazon.com/Healthy-Business-Health-Pharmaceutical-Industry/dp/0862327350/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1174978013&sr=1-1

HSL4049
Chren MM, Landefeld CS, Murray TH.
Doctors, drug companies, and gifts
JAMA 1990;263:2178-2179

HSL4050
Cockerill R.
Report on the 1989 survey of the dispensing practices and attitudes toward prescription drugs of Ontario pharmacists
1990;

HSL4052
Double standard labelling of pharmaceuticals sold in Thailand
Drug Study Group 1990;3

HSL4053
Duffin JM.
Junk mail
Canadian Medical Association Journal 1990;142:708

HSL4055
Erola J.
A sample response
Canadian Medical Association Journal 1990;143:129

HSL4056
Feather KR.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990;263:659

HSL4057
Gall JM.
Medifacts tapes and general practice
Canadian Family Physician 1990;36:419

HSL4058
Gelbart H.
Doctors, drug companies, and gifts
JAMA 1990;263:2177

HSL4059
Glass AR.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64

HSL4060
Goldstein M.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407

HSL4062
Gorski TN.
Doctors, drug companies, and gifts
JAMA 1990;263:2177

HSL4065
Herxheimer A.
Medicines in francophone Africa
Lancet 1990;335:1449-1450

HSL4067
Hume AL.
Doctors, drug companies, and gifts
JAMA 1990;263:2177-2178

HSL4068
Jason KM.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990;263:658-659

HSL4070
Jones K.
Advertising acyclovir
Lancet 1990;335:732

HSL4072
Kimbel KH.
Advertorials?
Lancet 1990;336:496

HSL4073
Lexchin J.
Disinformation from pharmaceutical company representatives
Canadian Medical Association Journal 1990;143:370

HSL4074
Lexchin J.
Drug makers and drug regulators: too close for comfort: A study of the Canadian situation
Social Science and Medicine 1990;31:1257-1263

HSL4075
Lexchin J.
The portrayal of the elderly in drug advertisements: a factor in inappropriate prescribing?
Canadian Journal on Aging 1990;9:296-303

HSL4076
Lexchin J.
Prescribing by Canadian general practitioners: review of the English language literature
Canadian Family Physician 1990;36:465-470

HSL4078
McSherry J.
Medifacts tapes and advertising
Canadian Family Physician 1990;36:850

HSL4079
Strom B.
Notes of the American Society for Clinical Pharmacology and Therapeutics: Position paper on the use of purported postmarketing drug surveillance studies for promotional purposes
Clinical Pharmacology and Therapeutics 1990;48:598

HSL4080
Morris LA, Banks DB.
New issues in drug advertising and labeling: the five advertising end-runs
Drug Information Journal 1990;24:639-646

HSL4082
Ethical aspects of phamaceutically based clinical investigation
Annals of the Royal College of Physicians and Surgeons of Canada 1990;23:436-438

HSL4084
Nidiry JJ.
Doctors, drug companies, and gifts
JAMA 1990;263:2178

HSL4085
Noble RC.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:408

HSL4086
Noble RC.
The pizza parade
Annals of Internal Medicine 1990;112:237

HSL4087
Odenbach E.
Collaboration with commercial interests in continuing medical education
Journal of Continuing Education in the Health Professions 1990;10:293-301

HSL4088
Peay MY, Peay ER.
Patterns of preference for information sources in the adoption of new drugs by specialists.
Soc Sci Med 1990;31:(4):467-76

HSL4090
Potter HP.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407

HSL4091
Pye J.
“Disinformation” from pharmaceutical company representatives
Canadian Medical Association Journal 1990;142:1178

HSL4093
Relman AS.
More on sex and racial bais in pharmaceutical advertisements
New England Journal of Medicine 1990;322:1534

HSL4094
Rendle MA.
Zopiclone (Imovane): evaluation in general practice
New Zealand Medical Journal 1990;103:225

HSL4096
Robertson WO.
Throw-away journals
Canadian Medical Association Journal 1990;142:708

HSL4097
Robinson WK.
A sample argument
Canadian Medical Association Journal 1990;143:611

HSL4098
Rodwin MA.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64

HSL4099
Roeg N.
The other drug trade
Adbusters 1990;1:(4):80-87
www.adbusters.org/adbusters/

HSL4100
Russell R, Nelson PJ, Ohri L.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:64-65

Page 185 of 202 pages ‹ First  < 183 184 185 186 187 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.